|
benzyl N-[[4-(hydroxymethyl)-2-oxabicyclo[2.1.1]hexan-1-yl]methyl]carbamate
|
B632977-250mg
|
≥97% |
2387602-11-9 |
250mg
|
¥ 4750.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
benzyl N-[[4-(hydroxymethyl)-2-oxabicyclo[2.1.1]hexan-1-yl]methyl]carbamate
|
B632977-1g
|
≥97% |
2387602-11-9 |
1g
|
¥ 14256.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
benzyl N-[[4-(hydroxymethyl)-2-oxabicyclo[2.1.1]hexan-1-yl]methyl]carbamate
|
B632977-100mg
|
≥97% |
2387602-11-9 |
100mg
|
¥ 2968.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-bromo-6,7-dihydro-5H-1,7-naphthyridin-8-one
|
B632972-500mg
|
≥97% |
2387601-17-2 |
500mg
|
¥ 4314.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-bromo-6,7-dihydro-5H-1,7-naphthyridin-8-one
|
B632972-250mg
|
≥97% |
2387601-17-2 |
250mg
|
¥ 2585.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-bromo-6,7-dihydro-5H-1,7-naphthyridin-8-one
|
B632972-1g
|
≥97% |
2387601-17-2 |
1g
|
¥ 7761.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-bromo-6,7-dihydro-5H-1,7-naphthyridin-8-one
|
B632972-100mg
|
≥97% |
2387601-17-2 |
100mg
|
¥ 1615.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-bromo-N,N-dimethyl-3-(trifluoromethyl)pyrazole-1-sulfonamide
|
B632961-5g
|
≥97% |
2387598-83-4 |
5g
|
¥ 5280.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-bromo-N,N-dimethyl-3-(trifluoromethyl)pyrazole-1-sulfonamide
|
B632961-1g
|
≥97% |
2387598-83-4 |
1g
|
¥ 1318.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-bromo-N,N-dimethyl-3-(trifluoromethyl)pyrazole-1-sulfonamide
|
B632961-10g
|
≥97% |
2387598-83-4 |
10g
|
¥ 10560.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
8-bromo-3-fluoro-naphthalene-1-carboxylic acid
|
B632954-500mg
|
≥97% |
2387597-18-2 |
500mg
|
¥ 9462.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
8-bromo-3-fluoro-naphthalene-1-carboxylic acid
|
B632954-250mg
|
≥97% |
2387597-18-2 |
250mg
|
¥ 5674.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
8-bromo-3-fluoro-naphthalene-1-carboxylic acid
|
B632954-1g
|
≥97% |
2387597-18-2 |
1g
|
¥ 17028.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
8-bromo-3-fluoro-naphthalene-1-carboxylic acid
|
B632954-100mg
|
≥97% |
2387597-18-2 |
100mg
|
¥ 3548.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1S,5S)-3-benzyloxycarbonyl-3-azabicyclo[3.1.0]hexane-1-carboxylic acid
|
B632939-5g
|
≥97% |
2387569-13-1 |
5g
|
¥ 23100.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1S,5S)-3-benzyloxycarbonyl-3-azabicyclo[3.1.0]hexane-1-carboxylic acid
|
B632939-500mg
|
≥97% |
2387569-13-1 |
500mg
|
¥ 3080.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1S,5S)-3-benzyloxycarbonyl-3-azabicyclo[3.1.0]hexane-1-carboxylic acid
|
B632939-250mg
|
≥97% |
2387569-13-1 |
250mg
|
¥ 1846.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1S,5S)-3-benzyloxycarbonyl-3-azabicyclo[3.1.0]hexane-1-carboxylic acid
|
B632939-1g
|
≥97% |
2387569-13-1 |
1g
|
¥ 4620.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1S,5S)-3-benzyloxycarbonyl-3-azabicyclo[3.1.0]hexane-1-carboxylic acid
|
B632939-100mg
|
≥97% |
2387569-13-1 |
100mg
|
¥ 1153.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3R)-7-bromo-5-methyl-3-(tritylamino)-2,3-dihydro-1,5-benzoxazepin-4-one
|
B632936-500mg
|
≥97% |
2387568-22-9 |
500mg
|
¥ 4050.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3R)-7-bromo-5-methyl-3-(tritylamino)-2,3-dihydro-1,5-benzoxazepin-4-one
|
B632936-250mg
|
≥97% |
2387568-22-9 |
250mg
|
¥ 2433.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3R)-7-bromo-5-methyl-3-(tritylamino)-2,3-dihydro-1,5-benzoxazepin-4-one
|
B632936-1g
|
≥97% |
2387568-22-9 |
1g
|
¥ 7294.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3R)-7-bromo-5-methyl-3-(tritylamino)-2,3-dihydro-1,5-benzoxazepin-4-one
|
B632936-100mg
|
≥97% |
2387568-22-9 |
100mg
|
¥ 1522.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
8-benzyloxycarbonyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid
|
B632908-500mg
|
≥97% |
2386366-89-6 |
500mg
|
¥ 4948.9
|
期货,请咨询 |
|
0 |
阿拉丁 |